Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0X3CD
|
||||
| Former ID |
DNCL002517
|
||||
| Drug Name |
Thiarabine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 1 | [1] | ||
| Company |
Access Pharmaceuticals
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C9H13N3O4S
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Human DNA | Target Info | Inhibitor | [2] | |
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT01139151) 4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies. U.S. National Institutes of Health. | ||||
| REF 2 | Enzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of Cancer. Chem Rev. 2009 July; 109(7): 2880-2893. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.